Intranasal delivery of HMGB1-binding heptamer peptide confers a robust neuroprotection in the postischemic brain

Neuroscience Letters

Volumn 525, Issue 2, 2012, Pages 179-183

  Kim, Il Doo ^a   Shin, Joo Hyun ^a   Lee, Hye Kyung ^a   Jin, Yin Chuan ^a   Lee, Ja Kyeong ^a  

^a Inha University School of Medicine   (South Korea)

Author keywords

HBHP; HMGB1; Intranasal delivery; MCAO; Neuroprotection

Indexed keywords

BIOTIN; HEPTAPEPTIDE; HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN BINDING HEPTAMER PEPTIDE; N METHYL DEXTRO ASPARTIC ACID; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BRAIN CORTEX; BRAIN ISCHEMIA; BRAIN NERVE CELL; CELL CULTURE; CELL DEATH; CULTURE MEDIUM; DRUG DELIVERY SYSTEM; DRUG PROTEIN BINDING; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; RAT; STROKE;

ADMINISTRATION, INTRANASAL; ANIMALS; BRAIN; BRAIN ISCHEMIA; CELLS, CULTURED; HMGB1 PROTEIN; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICE; NEURONS; NEUROPROTECTIVE AGENTS; OLIGOPEPTIDES; PEPTIDE LIBRARY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84865416670     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.07.040     Document Type: Article

References (20)

1. Agnello D., Wang H., Yang H., Tracey K.J., Ghezzi P. HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion. Cytokine 2002, 18:231-236.
2. Bonaldi T., Talamo F., Scaffidi P., Ferrera D., Porto A., Bachi A., Rubartelli A., Agresti A., Bianchi M.E. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO Journal 2003, 22:5551-5560.
3. Chen J., Sanberg P.R., Li Y., Wang L., Lu M., Willing A.E., Sanchez-Ramos J., Chopp M. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 2001, 32:2682-2688.
4. Dintilhac A., Bernués J. HMGB1 interacts with many apparently unrelated proteins by recognizing short amino acid sequences. Journal of Biological Chemistry 2002, 277:7021-7028.
5. Friggeri A., Yang Y., Banerjee S., Park Y.J., Liu G., Abraham E. HMGB1 inhibits macrophage activity in efferocytosis through binding to the alphavbeta3-integrin. American Journal of Physiology-Cell Physiology 2010, 299:1267-1276.
6. Huttunen H.J., Fages C., Kuja-Panula J., Ridley A.J., Rauvala H. Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. Cancer Research 2002, 62:4805-4811.
7. Ivanov S., Dragoi A.M., Wang X., Dallacosta C., Louten J., Musco G., Sitia G., Yap G.S., Wan Y., Biron C.A., Bianchi M.E., Wang H., Chu W.M. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood 2007, 110:1970-1981.
8. Jin Y.C., Kim S.W., Cheng F., Shin J.H., Park J.K., Lee S., Lee J.E., Han P.L., Lee M., Kim K.K., Choi H., Lee J.K. The effect of biodegradable gelatin microspheres on the neuroprotective effects of high mobility group box 1 A box in the postischemic brain. Biomaterials 2011, 32:899-908.
9. Kang R., Livesey K.M., Zeh H.J., Loze M.T., Tang D. HMGB1: a novel Beclin 1-binding protein active in autophagy. Autophagy 2010, 6:1209-1211.
10. Kim S.W., Jin Y., Shin J.H., Kim I.D., Lee H.K., Park S., Han P.L., Lee J.K. Glycyrrhizic acid affords robust neuroprotection in the postischemic brain via anti-inflammatory effect by inhibiting HMGB1 phosphorylation and secretion. Neurobiology of Disease 2012, 46:147-156.
11. Kim S.W., Lim C.M., Kim J.B., Shin J.H., Lee S., Lee M., Lee J.K. Extracellular HMGB1 released by NMDA treatment confers neuronal apoptosis via RAGE-p38 MAPK/ERK signaling pathway. Neurotoxicity Research 2011, 20:159-169.
12. Kim J.B., Sig Choi J., Yu Y.M., Nam K., Piao C.S., Kim S.W., Lee M.H., Han P.L., Park J.S., Lee J.K. HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. Journal of Neuroscience 2006, 26:6413-6421.
13. Kim I.D., Shin J.H., Kim S.W., Choi S., Ahn J., Han P.L., Park J.S., Lee J.K. Intranasal delivery of HMGB1 siRNA confers target gene knockdown and robust neuroprotection in the postischemic brain. Molecular Therapy 2012, 20:829-839.
14. Liu K., Mori S., Takahashi H.K., Tomono Y., Wake H., Kanke T., Sato Y., Hiraga N., Adachi N., Yoshino T., Nishibori M. Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. FASEB Journal 2007, 21:3904-3916.
15. Liu G., Wang J., Park Y.J., Tsuruta Y., Lorne E.F., Zhao X., Abraham E. High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine. Journal of Immunology 2008, 181:4240-4246.
16. Scaffidi P., Misteli T., Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418:191-195.
17. Sha Y., Zmijewski J., Xu Z., Abraham E. HMGB1 develops enhanced proinflammatory activity by binding to cytokines. Immunology 2008, 180:2531-7253.
18. Youn J.H., Kwak M.S., Wu J., Kim E.S., Ji Y., Min H.J., Yoo J.H., Choi J.E., Cho H.S., Shin J.S. Identification of lipopolysaccharide-binding peptide regions within HMGB1 and their effects on subclinical endotoxemia in a mouse model. European Journal of Immunology 2011, 41:2753-2762.
19. Youn J.H., Oh Y.J., Kim E.S., Choi J.E., Shin J.S. High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human monocytes. Journal of Immunology 2008, 180:5067-5074.
20. Zhang J., Takahashi H.K., Liu K., Wake H., Liu R., Maruo T., Date I., Yoshino T., Ohtsuka A., Mori S., Nishibori M. Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats. Stroke 2011, 42:1420-1428.